Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
05/2002
05/23/2002CA2771909A1 Proteins producing an altered immunogenic response and methods of making and using the same
05/23/2002CA2421182A1 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
05/22/2002CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use
05/14/2002CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
05/09/2002US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
05/02/2002EP1201137A1 Cysteine/glycine rich peptides
04/2002
04/30/2002US6379678 Culture product; antiallergens
04/30/2002CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
04/25/2002US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides
04/24/2002CA2359606A1 Cysteine/glycine rich peptides
04/18/2002WO2002030990A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof
04/18/2002WO2002030987A1 Antihuman heme oxygenase-1 monoclonal antibody
04/17/2002EP1196587A2 Antigenic meningococcal peptides
04/17/2002CN1344723A High-purity biliprotein separating process
04/11/2002WO2002012275A3 Lat peptides and their use in assays for identifying immunosuppressants
04/11/2002WO2001074898A8 Charged compounds comprising a nucleic acid binding moiety and uses therefor
04/11/2002WO2001051011A3 Condensation products of proteins, whereby azelaic acid is used
04/11/2002US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects
04/09/2002US6368877 Self-assembling peptide surfaces for cell patterning and interactions
03/2002
03/28/2002US20020037834 Process control; low temperature
03/27/2002EP1189623A2 Method and composition for inhibiting cardiovascular cell proliferation
03/26/2002US6362371 β2- adrenergic receptor agonists
03/19/2002US6359118 Carbohydrate crosslinked glycoprotein crystals
03/14/2002WO2002019822A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
03/14/2002WO2001057066A3 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin
03/14/2002CA2421391A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
03/13/2002EP0673652B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it
03/12/2002US6355805 β3-adrenergic receptor agonists
03/07/2002US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis
03/07/2002US20020028914 Chimeric toxins for targeted therapy
03/06/2002CN1339063A Human hybrid host cell for mammalian gene expression
02/2002
02/28/2002US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
02/14/2002WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants
02/13/2002CN1335323A Maggot protein
01/2002
01/31/2002WO2002008449A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases
01/31/2002WO2001025794B1 Protein fingerprinting by multisite labelling
01/31/2002US20020012948 Metallopeptide combinatorial libraries and applications
01/31/2002CA2417134A1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases
01/24/2002WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY
01/24/2002CA2410898A1 Substrates and assays for .beta.-secretase activity
01/23/2002CN1332176A Semi-dry microwave synthesis process of phosphoprotein
01/17/2002WO2002004014A1 New class of bioactive glycoprotein
01/17/2002CA2385142A1 New class of bioactive glycoprotein
01/16/2002EP1171604A2 Dna sequence and recombinant production of a graminae allergen
01/08/2002CA2166198C Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins
01/02/2002EP1165693A2 Squaraine dyes
01/01/2002US6335457 Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex
12/2001
12/27/2001WO2001098522A2 Positively-charged peptide nucleic acid analogs with improved properties
12/27/2001CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties
12/19/2001EP1163337A2 Vascular adhesion molecules and modulation of their function
12/13/2001WO2001094327A1 Catalyst comprising soluble polymer and polyamino acid
11/2001
11/29/2001US20010046680 Identification of polypeptides and nucleic acid molecules using linkage between DNA and polypeptide
11/20/2001US6319693 Cloning of chicken anemia virus DNA
11/15/2001WO2001086590A1 The use of proteinaceous molecules in methods for molecular computing
11/15/2001CA2408545A1 The use of proteinaceous molecules in methods for molecular computing
11/14/2001EP1154376A1 The use of proteinaceous molecules in methods for molecular computing
11/08/2001WO2001083507A1 Identification of polypeptides and nucleic acid molecules using linkage between dna and polypeptide
11/07/2001EP1151143A1 Selection of proteins using rna-protein fusions
11/01/2001WO2000047775A9 Selection of proteins using rna-protein fusions
10/2001
10/30/2001US6310179 2-or 3-dimensional geometric structures
10/25/2001WO2001025794A3 Protein fingerprinting by multisite labelling
10/24/2001CN1318553A New affinity chromatography medium and purification method for cobra neurotoxin
10/23/2001US6306612 Methods of facilitating vascular growth
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/16/2001US6303322 Testing in multiplicity of wells; generating thermal unfolding or denaturation curve; combinatorial chemistry; receptor binding assay
10/11/2001WO2001074898A2 Charged compounds comprising a nucleic acid binding moiety and uses therefor
10/11/2001CA2403537A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor
10/10/2001EP1141375A1 Metallopeptide combinatorial libraries and applications
10/10/2001EP1141272A1 Optical sorting method
10/10/2001EP1141242A2 Oocyte activation by sperm components
10/04/2001EP1137805A1 Methods of facilitating vascular growth
10/04/2001EP1137768A1 Human hybrid host cell for mammalian gene expression
10/04/2001EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
10/03/2001CN1315328A Protein resisting against plant mosaic virus
10/02/2001US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
09/2001
09/20/2001WO2001068673A1 Oligonucleotide analogues, methods of synthesis and methods of use
09/20/2001CA2402319A1 Oligonucleotide analogues, methods of synthesis and methods of use
09/19/2001EP0948522A4 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
09/19/2001CN1313903A Compound and method for the prevention and/or the treatment of allergy
09/19/2001CN1313290A Hydrolytic active substance of brain protein, its preparing process and its activity and sequence
09/18/2001US6291192 Method for identifying conditions that facilitate recombinant protein folding
09/18/2001US6291191 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization
09/12/2001EP1131056A1 Particles based on polyamino-acid(s) and methods for preparing same
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288055 Analgesic agents
09/11/2001US6287761 Synthetic antigens for the detection of antibodies to hepatitis C virus
09/11/2001CA2125175C New peptide derivatives
08/2001
08/30/2001WO2000074701A3 Method and composition for inhibiting cardiovascular cell proliferation
08/30/2001US20010018191 Immunology complex with epitopes; Alzheimer's disease
08/29/2001EP0547065B1 Melanin production by transformed microorganisms
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/16/2001WO1999064046A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
08/14/2001US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis
08/14/2001US6274344 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
08/09/2001WO2001057066A2 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin
08/09/2001WO2001004316A3 Antigenic meningococcal peptides
08/09/2001US20010012621 Determining the expression of lysyl oxidase, the expression of lysyl oxidase indicating that the compound is capable of suppressing ras functions
08/09/2001CA2399231A1 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin
07/2001
07/31/2001US6268218 Method for sensing and processing fluorescence data from multiple samples
07/31/2001US6268158 Generating thermal denaturation curve
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48